Sign inJoin waitlistJoin the waitlist

Ludimila Cavalcante

Physician · University of Virginia Medical Center

Credentials: · · · · · · · · · ·

History

University of Virginia Medical Center
2024–Present

McGaw Medical Center of Northwestern University
2016–2017
University of Wisconsin Hospitals and Clinics
2014–2016
Internal Medicine
Mount Sinai Medical Center of Florida, Inc
2011–2014
Federal University of Rio de Janeiro
2005–2009

Research

Precision medicine in colorectal cancer: the molecular profile alters treatment strategies
Review · Therapeutic Advances in Medical Oncology · 2015 · 58 citations
Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and LAG-3 and enhances…
Journal of Hematology & Oncology · 2022 · 44 citations
Anti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysis
Systematic review or meta-analysis · Clinical & Translational Oncology · 2021 · 44 citations

AS
Anwaar Saeed
17 papers
FG
Francis Giles
7 papers
Benedito Carneiro
5 papers
MC
Milena Cavalcante
4 papers · 1 as a resident
Andrew Coveler
3 papers
Azhar Saeed
3 papers · 3 as a fellow
Howard Safran
3 papers
Steven Powell
3 papers
Stijn Hentzen
3 papers · 3 as a resident
Timothy Murray
3 papers
Abdul Naqash
2 papers
Amy Schefler
2 papers · 2 as a fellow

Clinical trials

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Site PI · Recruiting · Phase 1
Inhibrx Biosciences, Inc
2018–2029